Inarigivir soproxil
目录号: A19335
innate immunity agonist
Inarigivir soproxil 是一种先天免疫激动剂,并且对抗性丙型肝炎病毒(HCV)变种显示出强大的抗病毒活性,其在基因型1 HCV 复制子系统中的细胞里对 HCV 1a/1b 的 EC50s 分别为 2.2 和 1.0 μM。
Discription | Inarigivir soproxil is an agonist of innate immunity and shows potent antiviral activity against resistant hepatitis C virus (HCV) variants, with EC50s of 2.2 and 1.0 μM for HCV 1a/1b in cells of genotype 1 HCV replicon systems. | |||||
---|---|---|---|---|---|---|
Cell Research |
|
目录号 | A19335 |
---|---|
分子式 | C25H34N7O13PS |
分子量 | 703.62 |
CAS号 | 942123-43-5 |
SMILES | CO[C@H]1[C@H](N(C=CC2=O)C(N2)=O)O[C@H](CO)[C@H]1OP(OC[C@H]3O[C@@H](N4C5=NC=NC(N)=C5N=C4)C[C@@H]3O)(SCOC(OC(C)C)=O)=O |
其他名称 | SB9200, SB 9200, SB-9200 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 96 mg/mL (136.44 mM) | |
Water | 24 mg/mL (34.11 mM) | ||
Ethanol | 58 mg/mL | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 14.21 mL | 71.06 mL | 142.12 mL |
0.5 mM | 2.84 mL | 14.21 mL | 28.42 mL |
1 mM | 1.42 mL | 7.11 mL | 14.21 mL |
5 mM | 0.28 mL | 1.42 mL | 2.84 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2